— Know what they know.
Not Investment Advice

INKT NASDAQ

MiNK Therapeutics, Inc.
1W: +7.8% 1M: -12.2% 3M: +2.4% YTD: -4.4% 1Y: -29.0% 3Y: +3.2% 5Y: -91.2%
$10.63
+0.20 (+1.92%)
 
Weekly Expected Move ±8.8%
$9 $10 $11 $12 $13
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $54.2M mcap · 1M float · 1.17% daily turnover · Short 53% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -62.56.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

2 relationships
1
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2022-08-05
Earliest Filing
2025-10-09
Latest Filing
partner: 1

Counterparties (Filed by INKT)

1 relationships

Companies named in INKT's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Agenus Inc. AGEN partner Entered into an Amended and Restated Intercompany Services Agreement for shared administrative, R&D, and facility suppor 2022-08-05 View

Mentioned As Counterparty

1 mentions

Other companies that named INKT in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
AGEN AGENUS INC partner Shares pledged as collateral for the Promissory Note 2025-10-09 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-13 Earnings Release View
2026-06-23 Shareholder Vote View
2026-05-15 Earnings Release; Exhibits View
2026-03-31 Earnings Release; Exhibits View
2026-03-27 Other Events View
2026-03-19 Officer/Director Change View
2026-01-02 Departure/Election of Directors; Appointment of Officers View
2025-12-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-29 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-08-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-15 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2025-07-14 Other Events View
2025-06-18 Submission of Matters to a Vote of Security Holders View
2025-05-15 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-03-18 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-21 Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde View
2024-11-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-10-31 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2024-10-18 Departure/Election of Directors; Appointment of Officers View
2024-08-30 Notice of Delisting or Transfer View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms